Who is this course for?
Healthcare professionals, mental health practitioners, and those interested in exploring the potential benefits of psychedelic therapy.
Intoxication & Dissociation in Psychedelic-Assisted Therapy is a two-hour introductory course aimed at exploring the potential benefits and drawbacks of the utilization of psychedelic substances in therapy.
Fluence
English
1 hour
Intoxication & Dissociation in Psychedelic-Assisted Therapy is a two-hour introductory course aimed at exploring the potential benefits and drawbacks of the utilization of psychedelic substances in therapy. The course challenges the long-standing assumption that states of intoxication and dissociation in psychedelic therapy are harmful to mental health. Instead, it examines their role in a potentially therapeutic process.
Participants will learn about the state of intoxication in psilocybin-assisted therapy models and how dissociative states during psychedelic experiences can be therapeutic. They will also compare and contrast dissociative states to psychedelic states and gain a deeper understanding of how psychedelic therapy works. This knowledge will help to advance the integration of psychedelic therapy into mainstream psychiatric and psychological discourse.
This course is designed for healthcare professionals, mental health practitioners, and those interested in exploring the potential benefits of psychedelic therapy. It will provide an overview of the current research and understanding of intoxication and dissociation in psychedelic therapy and equip participants with the knowledge needed to make informed decisions in their practice.
Healthcare professionals, mental health practitioners, and those interested in exploring the potential benefits of psychedelic therapy.
Fluence is a psychedelic therapy education company co-founded by psychologists Dr. Ingmar Gorman and Dr. Elizabeth Nielson, offering continuing education courses and a Certificate in Psychedelic Therapy and Integration for licensed therapists and advanced graduate students. Having trained 8,000+ clinicians, Fluence draws on its founders' direct experience in FDA-approved Phase 3 clinical trials of MDMA- and psilocybin-assisted therapies.
Healthcare professionals, mental health practitioners, and those interested in exploring the potential benefits of psychedelic therapy.
Format: Self-paced. Time commitment: 1 hour.
The listed price is $25. Confirm the latest tuition, fees, and payment options with [object Object].
The listing includes a certificate signal. Accreditation note: CE Credits. Listed CE/CME credits: 2. Confirm credential eligibility directly with the provider before enrolling.
The current listing status is No New Dates. Use the provider website for the latest enrollment status.
By Fluence
Shares course skills and categories
This 4-day in-person workshop is designed for therapists who want to learn about trauma-informed psychedelic-assisted therapy. It covers essential topics such as the impact of drug policy and systemic inequality on the provision and practice of psychedelic-assisted therapy, the role of intergenerati
Source lists: 1.5 hours
Delivery: Self-paced
No medicine self-experience listed
By Clerkenwell Health
Shares course skills and categories
Psilocybin therapy courses covering clinical and educational material on psilocybin-assisted psychotherapy, preparation, dosing, and integration. Listings on the page vary by provider and format.
Next cohort: May 20, 2026
By Fluence
Shares course skills and categories
Psychedelic Therapist Training covers the use of psychedelic substances in therapy, with topics including history, current research, safety, harm reduction, ethics, and session facilitation. It is presented as training for mental health and medical professionals, as well as others interested in psychedelic therapy.
Next cohort: Sep 1, 2026